IC
CMRX

Ikarian Capital’s Chimerix, Inc. CMRX Stock Holding History

Ikarian Capital’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-441,203
Closed -$917K – 167
2022
Q2 		$917K Sell
441,203
-400,000
-48% -$1.28M 0.17% 81
2022
Q1 		$3.85M Buy
841,203
+45,793
+6% +$255K 0.51% 49
2021
Q4 		$5.11M Sell
795,410
-5,898
-0.7% -$35.4K 0.76% 34
2021
Q3 		$4.96M Sell
801,308
-774,608
-49% -$5.33M 0.35% 66
2021
Q2 		$12.6M Sell
1,575,916
-21,598
-1% -$180K 1.02% 24
2021
Q1 		$15.4M Buy
1,597,514
+365,001
+30% +$3.35M 0.52% 45
2020
Q4 		$5.95M Sell
1,232,513
-131,531
-10% -$477K 0.26% 84
2020
Q3 		$3.4M Buy
+1,364,044
New +$4.03M 0.25% 84
2020
Q2 		– Sell
-208,258
Closed -$300K – 212
2020
Q1 		$300K Buy
208,258
+35,338
+20% +$61.8K 0.02% 139
2019
Q4 		$351K Buy
+172,920
New +$319K 0.06% 94

Other funds holding CMRX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital's CMRX Position: Q3 2022 in Review

Ikarian Capital sold out of Chimerix, Inc. (CMRX) in Q3 2022, closing a stake of 441,203 shares — an estimated $917K sold.

Ikarian Capital first reported a position in CMRX in Q4 2019 and held it in 10 quarters. The position peaked at $15.4M in Q1 2021. 118 funds tracked by Wall St. Rank hold CMRX as of Q3 2022.

  • Ikarian Capital reported no remaining Chimerix, Inc. position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 441,203 Chimerix, Inc. shares in Q3 2022, an estimated $917K.
  • Ikarian Capital first reported a position in Chimerix, Inc. in Q4 2019 and held it in 10 quarters.
  • Ikarian Capital's Chimerix, Inc. position peaked at $15.4M in Q1 2021.
  • 118 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.